Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions
Analgesic Effect of Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Femoral Endovascular Cardiac Interventions: A Prospective-randomized Study
1 other identifier
interventional
100
1 country
1
Brief Summary
Sensory innervation of the femoral region which is the entry point for endovascular cardiac interventions such as coronary angiography,cardiac catheterization and percutaneous coronary intervention is complex.It is thought that the ilioinguinal and iliohypogastric nerves contribute mostly.With transversus abdominis plane block(TAPB),it is planned to provide analgesia by creating a block in these nerve branches that contribute to the sensory innervation of the intervention area.In addition;it was aimed to investigate patient's and physician's satisfaction during the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2024
CompletedFirst Posted
Study publicly available on registry
August 28, 2024
CompletedStudy Start
First participant enrolled
September 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedSeptember 10, 2025
May 1, 2025
1.1 years
August 26, 2024
September 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
measuring the analgesic efficacy of TAPB
The pain will be assessed by the Numeric Rating Scale-11(NRS -11) to measure the analgesic efficacy of TAPB. Minimum pain score is point zero, maximum pain score is ten points.Minimum pain scores (NRS is less than 4 points) will have positive outcomes.
4 months
For patient and physician satisfaction;5-point Likert scale will be used. Minimum satisfaction score is one point, maksimum satisfaction score is five points.Higher scores have positive outcomes.
One point represents strongly unsatisfied and 5 points represent strongly satisfied.
4 months
Study Arms (2)
control group
SHAM COMPARATORonly local anesthesia will be applied to surgical field as a part of the routine procedure.
block group
ACTIVE COMPARATORlocal anesthesia will be applied to surgical field as a part of the routine procedure and additionally transversus abdominisl plane block will be applied.
Interventions
In additional to local anesthesia, 10 ml lidocaine (2%) (Lidon, Onfarma, Turkey ), TAPB will be performed under ultrasound imaging..
As routine procedure; the cardiologist will palpate the right or left femoral artery under sterile conditions and apply approximately 10 ml lidocaine (2%) to this area as local anesthesia (Lidon, Onfarma, Turkey ). Then, a puncture will be made on the anterior wall of the femoral artery with an 18 G needle . Approximately 3-4 mm skin incision will be made with the number 11 scalpel tip and the Seldinger technique will be continued. 6F femoral sheath to be placed, cardiac The catheterization process will begin.
Eligibility Criteria
You may qualify if:
- The patient is over 18 years of age
- Coronary angiography, cardiac catheterization and percutaneous coronary intervention will be applied to the patient,
- The above-mentioned procedures will be taken under elective conditions,
- Providing an optimal image when imaging the patient with ultrasound,
- INR\< 1.5
- If the patient gives consent, S/he will be included in the study.
You may not qualify if:
- Patients under 18 years of age,
- Patients treated under emergency conditions,
- morbid obesity (BMI\>35 kg/m2),
- pregnant women,
- New York Heart Association (NYHA) stage 4 patients with advanced decompensated heart failure,
- Patients with symptoms such as redness, temperature increase, infection, hematoma in the application area before the procedure,
- Patients with a history of allergy to local anesthetics,
- Patients who cannot be communicated,
- Those with severe psychosis or progressive neurological deficits and muscle disease,
- Patients who do not consent to the application will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University- Cerrahpasa
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kerem Erkalp
Proffessor
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- proffessor
Study Record Dates
First Submitted
August 26, 2024
First Posted
August 28, 2024
Study Start
September 10, 2024
Primary Completion
October 15, 2025
Study Completion
December 15, 2025
Last Updated
September 10, 2025
Record last verified: 2025-05